Can’t ChatGPT Do That? Practical Applications for AI in Drug Development
Deployed strategically, AI tools can revolutionize how organizations utilize data to discover insights that enhance…
CertaraOctober 30, 2023
Streamlining Pharmacokinetic Data Management with Certara’s Integral
The PK scientist's data pipeline handles a range of raw data types, including SAS, R,…
CertaraOctober 27, 2023
How biosimulation & AI tech could solve pharma’s R&D productivity crisis
Drug development continues to be painfully slow and mind-bogglingly expensive. In a 2010 article, Stephen…
CertaraOctober 27, 2023
Certara QSP Designer Technology
User-driven, graphical workspace to optimize collaboration for all stakeholders
CertaraOctober 25, 2023
Advancing rectal drug delivery: A breakthrough in physiologically based pharmacokinetic modeling
This blog explains how Certara’s Simcyp team developed and tested a model in the Simcyp…
CertaraOctober 20, 2023
RAPS Sponsored Webcast: Leveraging Today’s Technology to Accelerate Submissions: Real Life Examples and Lessons Learned
As the drug development industry strives to accelerate submission timelines and improve patient access to…
CertaraOctober 18, 2023
AAPS eChalk Talk: Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program
The development of new drugs for rare diseases is a challenging process due to small…
CertaraOctober 12, 2023
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader…
CertaraOctober 11, 2023
Regulatory initiatives for artificial intelligence applications: Regulatory writing implications
Medical Writing | Volume 32, Issue 3 - Artificial Intelligence and Machine LearningAuthor: Anjana Bose…
CertaraOctober 11, 2023
